1. Abrams R. Electroconvulsive therapy. New York: Oxford University Press, 1992.

2. American Psychiatric Association. Weiner RD, Fink M, Hammersley D, Moench L, Sackeim HA, Small I, eds. The practice of ECT: recommendations for treatment, training and privileging. Washington, DC: American Psychiatric Press, 1990.

3. Cole JO, Gardos G, Boling LA, Marby D, Haskell D, Moore P. Early dyskinesia—vulnerability. Psychopharmacology (Berl) 1992; 107:503–510.

4. Daniel WF, Crovitz HF. Acute memory impairment following electroconvulsive therapy. 1. Effects of electrical stimulus waveform and number of treatments. Acta Psychiatr Scand 1983;67:1–7.

5. Davis H, Squire L. Protein synthesis and memory. Psychol Bull 1984;96:518–559.

6. Davis JM, Janicak PG, Sakkas P, Gilmore C, Wang Z. Electroconvulsive therapy in the treatment of the neuroleptic malignant syndrome. Convulsive Ther 1991;7:111–120.

7. Decina P, Sackeim HA, Kahn DA, Pierson D, Hopkins N, Malitz S. Effects of ECT on the TRH stimulation test. Psychoneuroendocrinology 1987;12:29–34.

8. Devanand DP, Dwork AJ, Hutchinson ER, Bolwig TG, Sackeim HA. Does electroconvulsive therapy alter brain structure? Am J Psychiatry 1994;151:957–970.

9. Devanand DP, Sackeim HA, Lo ES, Cooper T, Huttinot G, Prudic J. Serial dexamethasone suppression tests and plasma dexamethasone levels. Effects of clinical response to electroconvulsive therapy in major depression. Arch Gen Psychiatry 1991;48:525–533.

10. Dinan TG, Barry S. A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic nonresponders. Acta Psychiatr Scand 1989;80:97–100.

11. Dodwell D, Goldberg D. A study of factors associated with response to electroconvulsive therapy in patients with schizophrenic symptoms. Br J Psychiatry 1989;154:635–639.

12. Exner JE Jr, Murillo LG. A long term follow-up of schizophrenics treated with regressive ECT. Dis Nerv Syst 1977;38:162–168.

13. Figiel GS, Coffey CE, Djang WT, Hoffman GJ, Doraiswamy PM. Brain magnetic resonance imaging findings in ECT-induced delirium. J Neuropsychiatry Clin Neurosci 1990;2:53–58.

14. Fink M. Convulsive therapy: theory and practice. New York: Raven Press; 1979.

15. Fink M. How does ECT work? Neuropsychopharmacology 1990; 3:77–82.

16. Fochtmann LJ, Cruciani R, Aiso M, Potter WZ. Chronic electroconvulsive shock increases D-1 receptor binding in rat substantia nigra. Eur J Pharmacol 1989;167:305–306.

17. Freeman CP, Weeks D, Kendell RE. ECT: II: patients who complain. Br J Psychiatry 1980;137:17–25.

18. Gardos G, Samu I, Kallos M, Cole JO. Absence of severe tardive dyskinesia in Hungarian schizophrenic out-patients. Psychopharmacology (Berl) 1980;71:29–34.

19. Goswami U, Dutta S, Kuruvilla K, Papp E, Perenyi A. Electroconvulsive therapy in neuroleptic-induced parkinsonism. Biol Psychiatry 1989;26:234–8.

20. Green A, Nutt D, Cowen P. Increased seizure threshold following convulsion. In: Sandler M, ed. Psychopharmacology of anticonvulsants. Oxford: Oxford University Press, 1982;16–26.

21. Hamilton M. The effect of treatment on the melancholias (depressions). Br J Psychiatry 1982;140:223–30.

22. Ingvar M. Cerebral blood flow and metabolic rate during seizures: relationship to epileptic brain damage. Ann NY Acad Sci 1986;462:194–206.

23. Janicak PG, Davis JM, Gibbons RD, Ericksen S, Chang S, Gallagher P. Efficacy of ECT: a meta-analysis. Am J Psychiatry 1985; 142:297–302.

24. Kalinowsky LB, Hoch PH. Shock treatments and other somatic procedures in psychiatry. New York: Grune & Stratton, 1946.

25. Kapur S, Mann JJ. Antidepressant action and the neurobiologic effects of ECT: human studies. In: Coffey CE, ed. The clinical science of electroconvulsive therapy. Washington, DC: American Psychiatric Press; 1993:235–250.

26. Khanna S, Gangadhar BN, Sinha V, Rajendra PN, Channabasavanna SM. Electroconvulsive therapy in obsessive-compulsive disorder. Convulsive Ther 1988;4:314–320.

27. Kragh J, Bolwig TG, Woldbye DP, Jørgensen OS. Electroconvulsive shock and lidocaine-induced seizures in the rat activate astrocytes as measured by glial fibrillary acidic protein. Biol Psychiatry 1993;33:794–800.

28. Krueger RB, Fama JM, Devanand DP, Prudic J, Sackeim HA. Does ECT permanently alter seizure threshold? Biol Psychiatry 1993;33: 272–276.

29. Krueger RB, Sackeim HA. Electroconvulsive therapy and schizophrenia. In: Hirsch SR, Weinberger DR, eds. Schizophrenia. Oxford: Blackwell [in press].

30. Krueger RB, Sackeim HA, Gamzu ER. Pharmacological treatment of the cognitive side effects of ECT: a review. Psychopharmacol Bull 1992;28:409–424.

31. Lambourn J, Gill D. A controlled comparison of simulated and real ECT. Br J Psychiatry 1978;133:514–519.

32. Mann SC, Caroff SN, Bleier HR, Welz WK, Kling MA, Hayashida M. Lethal catatonia. Am J Psychiatry 1986;143:1374–1381.

33. May PR, Tuma AH, Dixon WJ, Yale C, Thiele DA, Kraude WH. Schizophrenia. A follow-up study of the results of five forms of treatment. Arch Gen Psychiatry 1981;38:776–784.

34. McCall WV. Antihypertensive medications and ECT. Convulsive Ther 1993;9:317–325.

35. Mukherjee S, Debsikdar V. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy. Convulsive Ther [in press].

36. Mukherjee S, Sackeim HA, Schnur DB. Electroconvulsive therapy of acute manic episodes: a review of 50 years of experience. Am J Psychiatry [in press].

37. National Institute of Health Consensus Conference. Electroconvulsive therapy. JAMA 1985;254:2103–2108.

38. Nobler MS, Sackeim HA. Prediction of response to electroconvulsive therapy. In: Goodnick P, ed. Prediction of response to antidepressant treatments. Washington, DC: American Psychiatric Press [in press].

39. Nobler MS, Sackeim HA, Solomou M, Luber B, Devanand DP, Prudic J. EEG manifestations during ECT: effects of electrode placement and stimulus intensity. Biol Psychiatry 1993;34:321–330.

40. Nutt DJ, Glue P. The neurobiology of ECT: animal studies. In: Coffey CE, ed. The clinical science of electroconvulsive therapy. Washington, DC: American Psychiatric Press; 1993:213–234.

41. Ottosson J-O. Experimental studies of the mode of action of electroconvulsive therapy. Acta Psychiatr Scand [Suppl.] 1960;145:1–141.

42. Pataki J, Zervas IM, Jandorf L. Catatonia in a university inpatient service (1985–1990). Convulsive Ther 1992;8:163–173.

43. Post F. The management and nature of depressive illness in late life: a follow-through study. Br J Psychiatry 1972;121:393–404.

44. Post RM, Putnam F, Uhde TW, Weiss SR. Electroconvulsive therapy as an anticonvulsant. Implications for its mechanism of action in affective illness. Ann NY Acad Sci 1986;462:376–388.

45. Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 1990;31:287–296.

46. Riddle WJ, Scott AI, Bennie J, Carroll S, Fink G. Current intensity and oxytocin release after electroconvulsive therapy. Biol Psychiatry 1993;33:839–841.

47. Robin A, de Tissera S. A double-blind controlled comparison of the therapeutic effects of low and high energy electroconvulsive therapies. Br J Psychiatry 1982;141:357–366.

48. Royal College of Psychiatrists. Freeman CP, Crammer JL, Deakin JFW, McClelland R, Mann SA, Pippard J, eds. The practical administration of electroconvulsive therapy (ECT). London: Gaskell; 1989.

49. Rudorfer MV, Manji HK, Osman TO, Risby ED, Potter WZ. The biochemical effects of electroconvulsive therapy in depressed patients. I. Changes in cerebrospinal fluid monoamine metabolite concentrations. Arch Gen Psychiatry [in press].

50. Sackeim HA. Mechanisms of action of electroconvulsive therapy. In: Hales RE, Frances J, eds. Annual review of psychiatry. Vol. 7. Washington, DC: American Psychiatric Press; 1988:436–457.

51. Sackeim HA. The efficacy of electroconvulsive therapy in treatment of major depressive disorder. In: Fisher S, Greenberg RP, eds. The limits of biological treatments for psychological distress: comparisons with psychotherapy and placebo. Hillsdale, NJ: Erlbaum; 1989:275–307.

52. Sackeim HA. The cognitive effects of electroconvulsive therapy. In: Moos WH, Gamzu ER, Thal LJ, eds. Cognitive disorders: pathophysiology and treatment. New York: Marcel Dekker; 1992:183–228.

53. Sackeim HA. Use of electroconvulsive therapy in late life depression. In: Schneider LS, Reynolds III CF, Liebowitz BD, Friedhoff AJ, eds. Diagnosis and treatment of depression in late life. Washington, DC: American Psychiatric Press; 1993:259–277.

54. Sackeim HA, Decina P, Kanzler M, Kerr B, Malitz S. Effects of electrode placement on the efficacy of titrated, low-dose ECT. Am J Psychiatry 1987;144:1449–1455.

55. Sackeim HA, Devanand DP, Prudic J. Stimulus intensity, seizure threshold, and seizure duration: impact on the efficacy and safety of electroconvulsive therapy. Psychiatr Clin North Am 1991; 14:803–843.

56. Sackeim HA. Long J, Luber B, Prohovnik I, Devanand DP, Nobler MS. Physical properties and quantification of the ECT stimulus: I. Basic principles. Convulsive Ther [in press].

57. Sackeim HA, Prudic J, Devanand DP, Decina P, Kerr B, Malitz S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990;10:96–104.

58. Sackeim HA, Prudic J, Devanand DP, et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. N Engl J Med 1993;328:839–846.

59. Schwartz M, Silver H, Tal I, Sharf B. Tardive dyskinesia in northern Israel: preliminary study. Eur Neurol 1993;33:264–266.

60. Siesjö BK, Ingvar M, Wieloch T. Cellular and molecular events underlying epileptic brain damage. Ann NY Acad Sci 1986; 462:207–223.

61. Small JG, Klapper MH, Kellams JJ, et al. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry 1988;45:727–732.

62. Smith K, Surphlis WR, Gynther MD, Shimkunas AM. ECT-chlorpromazine and chlorpromazine compared in the treatment of schizophrenia. J Nerv Ment Dis 1967;144:284–290.

63. Squire LR. Memory functions as affected by electroconvulsive therapy. Ann New York Acad Sci 1986;462:307–314.

64. Taylor P, Fleminger JJ. ECT for schizophrenia. Lancet 1980; 1:1380–1382.

65. Thompson JW, Blaine JD. Use of ECT in the United States in 1975 and 1980. Am J Psychiatry 1987;144:557–562.

66. Thompson JW, Weiner RD. An update on the use of ECT in the United States. Am J Psychiatry [in press].

67. Ulett G, Smith K, Gleser G. Evaluation of convulsive and subconvulsive shock therapies utilizing a control group. Am J Psychiatry 1956;112:795–802.

68. Weiner RD, Rogers HJ, Davidson JR, Kahn EM. Effects of electroconvulsive therapy upon brain electrical activity. Ann NY Acad Sci 1986;462:270–281.

69. Weiner RD, Rogers HJ, Davidson JR, Squire LR. Effects of stimulus parameters on cognitive side effects. Ann NY Acad Sci 1986; 462:315–325.

70. Zielinski RJ, Roose SP, Devanand DP, Woodring S, Sackeim HA. Cardiovascular complications of ECT in depressed patients with cardiac disease. Am J Psychiatry 1993;150:904–909.

Back to Chapter